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The highly conserved protein eIF5A found in Archaea and all
eukaryotes uniquely contains the posttranslationally formed
amino acid hypusine. Despite being essential the functions of
this protein and its modification remain unclear. To gain more
insight into these functions temperature-sensitive mutants of
the human EIF5A1were characterized in the yeast Saccharomy-
ces cerevisiae. Expression of the point mutated form V81G in a
eIF5A strain of yeast led to a strongly temperature-sensitive
phenotype and to a significantly reduced protein level at restric-
tive temperature. The mutant showed accumulation of a subset
of mRNAs that was also observed in nonsense-mediated decay
(NMD)-deficient yeast strains. After short incubation at restric-
tive temperature the mutant exhibited increased half-lives of
the intron containing CYH2 pre-mRNA and mature transcripts
of NMD-dependent genes. Reduced telomere silencing and
shorteningwas detected in theV81Gmutant further supporting
similarities to NMD-deficient strains. Our data suggest that
eIF5A mediates important cellular processes like cell viability
and senescence through its effects on the stability of certain
mRNAs.
The cellular physiology of mRNA processing, transport,
localization, and turnover is central to the process of gene
expression at the posttranscriptional level. Increasing evidence
has been found for a close connection between mRNA degra-
dation processes and the steps of translation. The highly con-
served hypusine-containing protein eIF5A has been implicated
in both of these aspects of RNA metabolism; however, its pre-
cise cellular function is not yet fully understood.
Hypusine formation is a two-step enzymatic reaction cata-
lyzed by deoxyhypusine synthase and then deoxyhypusine hy-
droxylase (1). The disruption of genes encoding either eIF5A or
deoxyhypusine synthase in yeast leads to a lethal phenotype (2)
demonstrating that the deoxyhypusine residue is essential for
the function of eIF5A and thus for proliferation and cell sur-
vival. The genome of Saccharomyces cerevisiae contains two
HYP genes (HYP1, alias TIF51B or ANB1, and HYP2, alias
TIF51A) coding for eIF5A. These genes are differentially
expressed under aerobic and anaerobic conditions (3) and share
an identity of 90%. HYP genes of other higher eukaryotes, e.g.
one of the two humanHYP genes (encoding EIF5A1), can func-
tionally replace these yeast-specific genes (4, 5).
The eIF5A protein was first isolated from rabbit reticulocyte
lysate ribosomes and classified as a translation initiation factor
because in vitro the protein enhanced the building reaction of
the first peptide bond measured as the yield of methionine-
puromycin (6). However, cell fractionation revealed that only a
small fraction of the protein associated with ribosomes (7).
Moreover depletion or inactivation of the protein in S. cerevi-
siae reduced the global protein synthesis rate by only 30% (8, 9).
Thus, the role of eIF5A as a translation initiation factor remains
to be confirmed.
eIF5A is an RNA-binding protein (10), and it was hypothe-
sized to regulate the translation of a subset of mRNAs that are
needed for G1/S cell cycle progression because agents blocking
deoxyhypusine hydroxylase (11) or deoxyhypusine synthase
(12, 13) induced a cell cycle arrest at the G1/S boundary in
several mammalian cell types. These results were supported by
the G1 arrest at 37 °C of yeast cells expressing a temperature-
sensitive point mutated form of Tif51A (14).
The finding that eIF5A is a cellular cofactor of human immu-
nodeficiency virus type 1 Rev and human T-cell lymphotrophic
virus type 1 Rex transactivator proteins in mRNA export and
the interaction of eIF5A with the general exportin Crm1p for
nuclear export signal-containing proteins in higher eukaryotes
suggested it played a role in nucleoplasmatic shuttling of
mRNA (15–17). However, although the proteinwas found to be
located in the nucleus and the cytosol of COS-7 cells (18), active
shuttling between both compartments could not be confirmed.
Also a direct interaction between Rev and eIF5A has not been
shown (19). In addition yeast strains expressing temperature-
sensitive mutants of Crm1p did not show a mislocalization of
eIF5A to the nucleus (20). Therefore the nuclear export
hypothesis has been questioned.
The implication of eIF5A in mRNA degradation initially
came from studies of a temperature-sensitive HYP2 mutant
(ts1159) that showed an accumulation and a strongly prolonged
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half-life of unsplicedCYH2mRNA (9). The genetic background
of this strain, however, reveals a functional HYP1 introducing
the possibility that it might affect the observed phenotypic
effects.
Two studies revealed a connection between eIF5Aand senes-
cence processes showing a transcriptional up-regulation of
deoxyhypusine synthase and eIF5A in aging tomato plants (21,
22). However, in mammalian IMR-90 cells senescence led to a
distinct attenuation of the hypusine formation (23). So far the
cellular mechanism by which eIF5A is involved in cell aging is
not known.
Using yeast as a model system in which both native HYP
genes were disrupted we describe the effects of expressing the
point mutation V81G in the human hypusine-containing pro-
tein eIF5A1. We observed strong temperature sensitivities in
these yeast strains. Expression of themutant protein resulted in
the accumulation of nonsense-containing RNAs, which are
known to be specifically degraded by the polyadenylation-inde-
pendent 5–3 mRNA decay pathway (nonsense-mediated
decay (NMD)2). Additionally elongated half-lives of selected
NMD transcripts and shortened telomeres were observed.
These results suggest a functional connection of eIF5Awith the
NMD machinery that is coupled to translation initiation and
reinforce the notion that the protein might influence essential
cellular functions via its role in RNA processing.
EXPERIMENTAL PROCEDURES
Yeast Strains, Plasmids, and Growth Conditions—Yeast cells
were grown either on semisynthetic mediumwith 2% galactose
or 2% glucose or on yeast-peptone-dextrosemedium and yeast-
peptone-galactose medium (24). The plasmid shuffle with and
without 5-fluoroorotic acid as selective agent was performed as
described previously (25). S. cerevisiae strains used in this study
are listed in Table 1. The disruption of the HYP1 gene was
performed with the haploid strain WDH#6–9[YEpHYP2] (3)
bearing a disruption ofHYP2 by a 2.22-kb LEU2 fragment. The
HYP1 gene (cloned as a 1.94-kb EcoRI-BamHI fragment in a
plasmid derived frompBluescript; Stratagene)was disrupted by
insertion of a 1.6-kb SmaI-AatII fragment carrying the TRP1
marker gene into the single SalI site of theHYP1 coding region.
From the resulting vector a linear 3.6-kb EcoRI-BamHI frag-
ment was used for homologous recombination according to
Rothstein (26). Correct integration was verified by Southern
analysis. Isolation of high molecular weight genomic yeast
DNA, cloning, and in vitro mutagenesis of DNA were per-
formed as described previously (24, 31). PCR amplification was
used to clone the coding regions of different wild-type and
point mutatedHYP genes according to the properties of multi-
ple cloning sides in the target vectors. The plasmids used and
produced for this study are listed in Table 2. The constructs for
HYP expression either harbored the coding sequence of the
HYP2 gene (S. cerevisiae) or the cDNAof the humanHYP1 gene
EIF5A1. Transformation of yeast strains was performed using
the lithium ion method (32).
Anti-eIF5A Western Blotting—To determine eIF5A levels in
V81G mutant strains, cells were grown to an A600 of 1 at 25 °C
or shifted to 37 °C and incubated at this temperature for a fur-
ther 6 h. SDS-PAGE and immunoblotting were performed as
described previously (33) using a 1:10,000 dilution of polyclonal
antiserum against human EIF5A1 and enhanced chemilumi-
nescence detection (GE Healthcare).
MTTCellViabilityTest—AnMTTviability assayofmutantand
wild-type yeast cells was performed as described previously (34).
Terminal Deoxynucleotidyltransferase-mediated dUTP Nick
End Labeling (TUNEL)—The TUNEL assay and appropriate
cell preparations were performed as described previously (35)
2 The abbreviations used are: NMD, nonsense-mediated decay; FITC, fluores-
cein isothiocyanate; GAPDH, glyceraldehyde-3-phosphate dehydrogen-
ase; HDOA, high density oligonucleotide array; LTR, long terminal repeat;
MTT, 3-(4,5-dimethylthizole-2yl)-2,5-diphenyltetrazolium bromide; ORF,
open reading frame; ts, temperature-sensitive; TUNEL, terminal deoxynucleo-
tidyltransferase-mediated dUTP nick end labeling; Ty, transposon yeast; fmk,
fluoromethyl ketone; PD, population doubling.
TABLE 1
Yeast strains used in this study
Strain Genotype Source or Ref.
W303-1MATa MATa, leu2-3, 112, ura3-1, 112, his3-11, 15, trp1-l, 15, ade2-l, can1-100 26
WDH#6-9YEpHYP2 MATa, hyp2::LEU2, HYP2, YEp (URA3) else isogenic to W303-1MATa 4
W303h1h2 MATa, hpy1::TRPI, hyp2::LEU2, HYP2, YEp (URA3) else isogenic to W303-1MATa This study
WDHyp2-Gal MATa, hyp1::TRPI, hyp2::LEU2, HYP2, pRS This study
WDH(hum)Gal MATa, hyp1::TRPI, hyp2::LEU2, EIF5A1, pRS This study
WDHG81Gal MATa, hyp1::TRPI, hyp2::LEU2, EIF5A1-V81G, pRS This study
PLY118 MATa upf1-1::URA3 ura3-52 trp1-7 leu2-3,112 2 his4-38 27
TABLE 2
Plasmids used in this study
Plasmid Description Ref.
YEp352 2, LacZ, amp,MCS, URA3 28
YEpHYP2 YEp352 containing yeast wild-type HYP2 including its genomic promoter (cloned as PstI fragment) This study
pRS315 pBluescript, LEU2, CEN6, ARSH4, AmpR, LacZ 29
pRSG313 pRS313 containing the GAL1 promotor fragment cloned EcoRI BamHI 3
pRSG316 pRS316 containing the GAL1 promotor fragment cloned NotI SalI This study
pRSG313-HYP2 pRSG313 expressing the yeast wild-type Hyp2p 3
pRSG313-EIF5A1 pRSG313 expressing human wild-type EIF5A1 This study
pRSG313-EIF5A1G81 pRSG313 containing point mutated (V81G) human EIF5A1 fragment cloned BamHI/XbaI This study
pAA79 LEU2, CEN6, ARSH4, UPF1 (genomic promotor) 27
pCM189 URA3, ampr, lacZ, CEN6, tTA (tetR promotor moiety) 30
pCM189-EIF5A1 pCM189 containing human EIF5A1 fragment cloned BamHI/PstI This study
pCM189-EIF5A1G81 pCM189 containing point mutated (V81G) human EIF5A1 fragment cloned BamHI/PstI This study
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using the In Situ Cell Death Detection kit (Roche Applied Sci-
ence). Coverslips were mounted with a drop of 5% n-propyl
gallate (Sigma) in glycerol (100%). Slides were analyzed by flu-
orescence microscopy.
Measurement of Caspase Activation—In vivo staining of
caspase activity by flow cytometric analysis was performed as
described previously (36) using FITC-VAD-fmk (CaspACE,
Promega) and a FACSCalibur system (BD Biosciences). Wild-
type cells treated with 3 mM H2O2 served as a positive control.
Generation of Gene Expression Datasets by Microarray
Analysis—For high density oligonucleotide array (HDOA)
analysis total RNA was isolated using the hot phenol method
(37) from cultures grown at 25 °C reaching early logarithmic
phase. For each experiment RNA was independently isolated
from four isogenic yeast strains of the wild type and themutant
(strains WDH(hum)Gal and WDHG81Gal), and in vitro tran-
scriptions and hybridizations were performed. Thus, a total of
eight chips were included in the analysis (4 replicates  2 data-
sets for the wild type and the mutant V81G). RNA was further
purified with RNeasy columns (Qiagen). In brief 30 g of total
RNA were subjected to a cDNA synthesis reaction to make the
first strand using an oligo(dT) primer with a T7 promoter
sequence added to the 5-end. After synthesis of the second
strand, double-stranded cDNA was purified by phenol/chloro-
formextraction, precipitated, and resuspended in nuclease-free
water. Biotin-labeled cRNA was made by in vitro transcription
using the High Yield Transcription kit (ENZO Diagnostics).
The resulting cRNA was fragmented at 94 °C for 35 min in
buffer A (40 mM Tris acetate, 100 mM KOAc, and 30 mM
Mg(OAc)2). Affymetrix yeast S98 GeneChip arrays were
hybridized, washed, stained, and scanned according to the
manufacturer’s specifications. Scanned raw data images were
processed with Affymetrix GeneChip Version 3.2 software.
Normalization and Statistical Analysis of Hybridization
Data—Data from the arrays was normalized, and expression
values based on an additive model were calculated according to
the method of Irizarry et al. (38). Differentially expressed genes
were identified by the permutation-based method of Tusher
et al. (39). Briefly to control for multiple testing, a false discov-
ery rate (40) was calculated as the percentage of genes falsely
detected as differentially expressed among all genes detected as
differentially expressed. The q value is the lowest false discovery
rate at which the gene is called significant. Significant genes
were identified if they exhibited the lowest q value computed by
SAM (“Significance Analysis of Microarrays”) software. Detailed
information regarding the analysis performed on the microarray
data can be found in the supplemental data section. Primary array
datasets were published in the gene expression and hybridization
array data repository of the National Center for Biotechnology
Information (Gene Expression Omnibus (GEO), www.ncbi.nlm.
nih.gov/geo/, accession number GSE5290). The transcriptomic
profiles of V81G with NMD-deficient yeast were compared
with the original .cel files published by He et al. (41) and are
available at www.ebi.ac.uk/miamexpress/ under accession
numbers E-MEXP-26 and E-MEXP-27. These datasets were
analyzed in exactly the same way as the microarray data pro-
duced for this study.
Northern Blotting and Determination of mRNA Half-lives—
Yeast strains were cultured until they entered early log phase at
either 25 or 37 °C. Total RNA was isolated as before (37).
Northern blotting was carried out as described previously (42).
RNA was detected by hybridization to digoxigenin-labeled
DNA probes of about 350 bp in length that were prepared by
PCR using yeast genomic template DNA. After hybridization
and stringent washing signal detection was performed using
anti-digoxigenin antiserum (Roche Applied Science). Quantifi-
cation of RNA bands was performed using densitometry. The
stability of selected mRNAs was determined according to
Parker et al. (43). Briefly 200 ml of mutant and wild-type yeast
strains were grown toA600  0.7 and incubated for 1 h at either
25 or 37 °C. Next transcription was inhibited by the addition of
thiolutin (20 g/ml), and subsequent samples were taken at 0-,
4-, 8-, 16-, 32-, and 64-min intervals and frozen quickly in a dry
ice-ethanol bath. Subsequently total RNA was isolated, and 10
g of RNA/lanewas analyzed byNorthern blotting as described
above.
Quantitative Real Time (Reverse Transcriptional) PCR—Gene-
specific primerswere designedwith the PrimerExpress software
(Applied Biosystems). The antisense primers were used for
reverse transcription with avian myeloblastosis virus reverse
transcriptase (Promega) according to the manufacturer’s
instructions and using 2 g of total RNA. Real time PCR was
performed using SYBR Green PCR Master Mix and a Gene-
Amp5700 sequence detection system (Applied Biosystems)
according to the protocols of the manufacturer. Relative
expression levels were calculated, and PCR efficiencies were
determined as described previously by Pfaffl (44) and Ramakers
et al. (45), respectively, using ACT1 expression for normaliza-
tion. For each RNA preparation tested a minimum of three
independent real time (reverse transcriptional) PCR experi-
ments were conducted.
Determination of Telomere Length by Southern Analysis—
Telomere lengths were determined as described previously
(46). Briefly a probe containing a telomere repeat sequence was
prepared by 5-end labeling of the oligonucleotide Tel-Rep4
(CACCACACCCACACCCACACCACACCCACACACCCA-
CAC) with digoxigenin. The sequence was identical to 2.5
repeats of the telomere template sequence from the chromo-
some 8 analogue to TLC1. Total genomic DNA was digested
with PstI, and Southern blotting was performed as before. Sig-
nal development was achieved by using the DIG (digoxigenin)
Luminescent Detection kit (Roche Applied Science) according
to the manufacturer’s instructions.
RESULTS
Isolation of the Temperature-sensitive Point Mutant V81G—
To study the relationship between structure and function in the
human EIF5A1 hypusine-containing protein point mutations
were made throughout the entire length by exchanging phylo-
genetically conserved residueswith related amino acids. A yeast
strain was constructed (W303h1h2) in which both the genes
HYP2 andHYP1 (ANB1) encoding for the hypusine-containing
protein were disrupted (3). The strain harbored a 2-URA3-
plasmid-borne wild-type copy of the genomicHYP2, thus com-
plementing the otherwise lethal phenotype. The constructs
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containing the point mutations to be tested were cloned into
pRS313 containing the GAL promotor and transformed into
the W303h1h2 cells. The exchange of the wild type for a
mutated allele was performed by selective plasmid shuffling
using fluoroorotic acid. Because hypusine is essential, cell death
occurred if themutant allele cloned in pRS313 was incapable of
complementing the gene function of the wild type. This coun-
terselectionwas used to screen all mutations in the humanHYP
homologue EIF5A1.
The expression of certainmutated alleles resulted in temper-
ature-sensitive yeast strains. The strongest temperature sensi-
tivity was observed by the substitution of the valine residue at
position 81 (Fig. 1). Proliferation of cells at the restrictive tem-
perature was stopped after only one round of doubling when
valine at position 81 was mutated to a glycine (V81G). In
comparison with wild type the growth of the mutated strain
at the permissive temperature was decelerated. Retransfor-
mation of the mutant strains with a single copy plasmid
carrying wild-type human EIF5A1 completely restored the
temperature sensitivity (Fig. 1C) indi-
cating that it was not a recessive
mutation. Several independent trans-
formations and subsequent 5-fluo-
roorotic acid selections reproducibly
showed the pronounced phenotype
of the mutant V81G. These mutated




at 37 °C—Complete cell lysates
were prepared from wild-type or
mutant cells after incubation at per-
missive or restrictive temperatures
(Fig. 2). The eIF5A protein levels in
each case were determined by
Western blotting. At 25 °C the
mutated protein was expressed to
nearly the same amount as the wild type. Within 60 min after
heat shock induction the level of the eIF5A (V81G) protein
declinedmore than 5-fold. A further 5-h incubation at 37 °C did
not result in further changes in the protein level.
The viability of V81G-expressing cells at both temperatures
was checkedwith anMTTassay (Fig. 3). Independently isolated
strains of the mutant V81G and the corresponding wild-type
strains that were in early logarithmic growth phase were tested
at both the restrictive and the permissive temperatures. Fig. 3
shows that the formation of blue formazan from the activity of
dehydrogenases was similar for the wild-type cultures grown at
either the restrictive or the permissive temperature. Slight dif-
ferences were observed between wild-type HYP2 expression in
yeast and heterologous (human) EIF5A1 expression. However,
even at the permissive temperature, V81G, although capable of
growth, displayed a 50% reduction in viability when compared
with the wild type. After a 6-h incubation at 37 °C the viability
was further decreased.
To determine whether the mutant’s loss of cell viability was
due to apoptotic death a TUNEL assay was performed, and the
results are shown in Fig. 4B. No fluorescence was detected in
the control cells expressing wild-type eIF5A regardless of the
growth conditions. However, addition of 3 mMH2O2 and incu-
bation for 6 h at 37 °C rendered the cells positive for DNA
breaks, which served as a positive control. At the permissive
temperature (25 °C) the V81G mutant did not show any fluo-
rescent nuclei. In contrast, after 4 h at the restrictive tempera-
ture (37 °C) clear fluorescence in the nuclei was visible and
increased with longer incubation times.
To determine whether endogenous caspases were activated
in the mutant as a result of the induction of apoptosis a flow
cytometric assay was performed. Yeast cells were incubated in
vivo with FITC-labeled VAD-fmk (FITC-VAD-fmk), which
specifically binds to the reactive center of active caspases in
eukaryotic cells (36). Fig. 4Aii shows that incubation of mutant
cultures at 37 °C for 6 h activated caspases in 33%of the counted
cells. An equal fraction of apoptotic cells was detected in wild-
type cultures inwhich apoptosis was induced by treatmentwith
3 mM H2O2. In contrast the V81G mutant strain showed no
FIGURE 1. Growth characteristics of yeast strains expressing point mutated forms of human EIF5A1.
A, growth kinetics at 37 °C of a haploid W303h1h2 strain carrying two disrupted HYP genes complemented
with either wild-type human EIF5A1 or various point mutants of residue 81 of the human EIF5A1. Substitution
of Val-81 for Gly led to the strongest growth inhibition. B, growth kinetics of the V81G strains (two independ-
ently isolated mutant strains) at the permissive (25 °C) and restrictive temperatures. C, complementation of the
V81G mutated HYP with wild-type human EIF5A1. 1 and 2, two isogenic strains expressing the V81G protein; 3,
mutant strain from position 1 retransformed with a single copy plasmid expressing human wild-type EIF5A1
shows a clear reversibility of the temperature-sensitive phenotype. WT, wild-type.
FIGURE 2. Protein expression of wild-type and V81G mutated human
eIF5A in yeast. Cells were incubated at 25 or at 37 °C for the indicated times
and were subsequently harvested to prepare complete cell lysates. Equal
amounts of total protein from mutant and wild-type strains were separated
by SDS-PAGE. Western blotting was performed with a rabbit polyclonal anti-
serum against the human EIF5A1 protein. Equal loading of all lanes was con-
firmed by densitometric scanning of the Coomassie-stained gel prior to blot-
ting as well as quantification of the actin 1 protein on the Western blots that
was equally expressed in wild-type and mutant strains. WT, wild type.
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caspase-activated cells in cultures that had been incubated for a
shorter time (3 h) at a higher temperature or at 25 °C. Pro-
pidium iodide fluorescence can be used to detect cells that have
died independently of necrotic or apoptotic triggers. As nearly
all propidium iodide-positive cells also showed FITC-VAD-
fmk fluorescence (accumulation of cells in the upper right
region R1 of the dot blot, Fig. 4Ai cell death in these cells occurs
by apoptosis rather than by necrosis. In summary the results
show that incubation at 37 °C but not at 25 °C led to phenotypic
effects related to programmed cell death in the V81G strain.
Due to the V81G growth characteristics, all subsequent exper-
iments were performed with the V81G strain that had been
incubated either at 25 °C or at 37 °C less than 1 h.
Genome-wide Transcriptome Analysis of the Mutant V81G
Strain—To identify transcripts regulated by eIF5A, RNA
expression profiles of wild-type and V81G strains cultured at
the permissive temperature were analyzed. HDOAs were used
that covered the whole yeast genome (47). On the array, 9275
probe sets encoding 7839 yeast genes were present of which
6068 genes (6337 probe sets) were coding for proteins, hypo-
thetical proteins, or open reading frames. A group of “further
elements” contained 767 probe sets representing rRNA, tRNA,
small nucleolar RNA, and small cytoplasmic RNA as well as
transcripts derived from Ty retrotransposal RNAs and their
LTR sequences were also observed. All probe sets representing
mitochondrial encoded transcripts were found among a group
of “further ORFs” (Table 3) consisting of 2171 probe sets
including putative or non-annotated ORFs postulated by the
yeast genome sequencing project or serial analysis of gene
expression.
cRNA probes derived from total RNA preparations were
obtained from four isogenic, haploid strains from each of the
wild type and the mutant. This ensured that changes in the
transcriptome could be attributed to the impaired HYP func-
tion of V81G rather than to differences in the genetic back-
ground. Therefore, two groups of four datasets (per wild-type
and mutant strains) were generated after hybridization to the
HDOAs. The robust multichip average procedure (“Experi-
mental Procedures”) could be used for the normalization of all
samples because we showed that the quantification of the abso-
lute RNA amounts that were spiked prior to cDNA synthesis
were found to be identical. Transcripts were classified as differ-
entially expressed if they could be assigned to the lowest q value
of 0.08796% indicating a high level of significance.
In this way the pairwise comparison of the transcriptomes of
the V81G and wild-type strains resulted in 604 differentially
expressed transcripts (Table 3). 415 (421 probe sets) showed
up-regulation, and 188 (205 probe sets) showed down-regula-
tion. These two transcript groups served as the basis for the
following evaluations. A functional classification of up- and
down-regulated genes and ORFs in V81G mutant strains
(according to Ref. 48) can be found in the supplemental data to
this study (see supplemental Fig. S1). The temperature shift
from 25 to 37 °C and a 3-h period of incubation at high temper-
ature barely had any effect on the distribution of gene functions
(data not shown).
Partial Abrogation of the Telomere Position Effect and
Enrichment of Ty Retrotransposal RNAs—345 accumulating
ORFs in V81G (without those found by serial analysis of gene
expression) were analyzed with regard to their chromosomal
location.We found that 29.3% of the ORFs in the yeast genome
(119 of 406) were within a 27-kb region of the telomeres. These
subtelomeric ORFs were up-regulated in the mutant strains. In
contrast only 3.4% of the non-telomerically encoded ORFs of
the yeast transcriptome (199 of 5863 ORFs; without Ty and
LTR elements) were up-regulated. Furthermore a connec-
tion between the level of enrichment and the number of
telomeric transcripts was seen. Of the 345 ORFs the greatest
enrichment was observed for the ORFs closest to the
telomeres (subtelomeric), whereas the bulk of the remaining
ORFs that showed less enrichment were found further from
the telomeres (see Fig. 5).
Genes located nearby chromosomal telomeres are transcrip-
tionally repressed in S. cerevisiae. This chromosomal area con-
tains a lower density of ORFs than other regions. The phenom-
enonwas named the telomere positioning effect (49). Normally
the telomere positioning effect rapidly decreases as the distance
between an ORF and the telomere increases. At every telomere
a number ofORFswere found for which transcriptional activity
was not altered when compared with the wild type. Thus, refer-
ring to the data, the telomere positioning effect in the mutant
V81Gwas reduced but was not completely abolished compared
with the wild type.
Retrotransposons and their controlling elements repre-
sent 0.9% of the entire ORFs in the whole yeast genome.
FIGURE 3. MTT viability assay of mutant and wild-type cultures incubated
with MTT for 2 h at the permissive and restrictive temperatures. Two
independently isolated clones of each strain (WDH(hum)TO, WDHyp2TO, and
WDHG81TO) were tested. Cell density of all cultures was normalized to 510
8
cells/ml, and isopropanolic cell extracts were measured at 570 nm. This OD
value was proportional to the amount of blue formazan that was formed
during reduction time. Error bars indicate the standard deviation of triplicate
measurements of each of the two isogenic strains. Student’s t tests for inde-
pendent samples performed on every pair of strains in all cases generated
p values below 0.05, indicating significance of the results. WT, wild type.
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When we compared this to the
pool of transcripts that were
increased in the V81G strain we
found that this number increased
to 10% of the total transcripts (see
supplemental Fig. S1). The num-
ber of enriched Ty retrotransposal
transcripts including two Ty4 and
two Ty3 full-length RNAs and
about 40 transcripts coding for
LTR elements of all five kinds of
retrotransposons (Ty1–5) are
shown in Fig. 5 (for details see sup-
plemental data file Array-Data-
S4). Of these most LTRs origi-
nated from Ty1 and Ty4 elements.
Interestingly we observed a signifi-
cant portion of the accumulating
transcripts (15%) near the Ty retro-
transposons or LTR sequences
remaining from former retrotranspo-
sition processes. Especially interest-
ing was a position upstream of the
5-end of a Ty-LTR that led to accu-
mulation of the RNA of the corre-
sponding adjacent ORF. This points
to eIF5A playing a role in processes
involving retrotransposons.
Significant Overlap of the V81G-
accumulating Transcriptome with
Those of Strains Deficient in 5–3
mRNA Degradation—We repro-
ducibly found a 4-fold up-regula-
tion of theUPF2mRNA. The corre-
sponding protein together with
Upf1p and Upf3p function as trans-
acting factors of the mRNA NMD
pathway. This pathway also includes
themRNAdecapping enzymesDCP1
and DCP2 and the 5-exonuclease
XRN1. Of all genes belonging to the
NMD pathway only the UPF2 tran-
FIGURE 4. Test for apoptotic death in growth-arrested cells of V81G. A, i and ii, measurement of caspase
activation. After cultivation cells from wild-type and V81G strains were stained for active caspases with the
caspase substrate FITC-VAD-fmk and analyzed by flow cytometry (Ai) counting 25,000 cells of each strain.
Treatment of wild-type cultures with 3 mM H2O2 for 6 h induced apoptosis in 35% of the cells (positive
control) represented by accumulation of cells in the upper right quadrant (region 1 (R1)) of the dot blot.
Staining with propidium iodide (PI) enabled the apoptotic fraction to be distinguished from the necrotic
fraction (region 2 (R2)). Incubation of the V81G strains at 37 °C for 6 h but not at permissive temperature
led to the activation of caspases in a fraction of cells that was comparable to that found in the positive
control. Aii, a quantitative comparison of necrotic and apoptotic cell fractions. Bars represent the percent-
age of the cells counted in regions 1 and 2 from four independent experiments (mean  S.D.). The results
obtained from two isogenic strains of the mutant are included. B, TUNEL assay of wild-type and V81G
mutated strains. Wild-type cells cultivated at 25 and 37 °C were used as negative controls. 1, cells of V81G
cultured at 25 °C; 2, V81G cells after incubation at 37 °C for 6 h; 3, positive control of wild-type cells
incubated in the presence of 3 mM H2O2 for 6 h at 37 °C; 4, wild type cultivated at 37 °C (6 h). Only V81G cells
incubated at restrictive temperature showed clear fluorescence of nuclei due to antibody detection of
double strand breaks of nucleosomic DNA. WT, wild type.
TABLE 3












eIF5A-V81G-ts 0.08796 298 32 85 415 163 4 21 188 604
upf1 0.07775 380 39 105 524 38 1 2 41 565
upf2 0.06749 376 36 90 502 48 6 9 63 565
upf3 0.05349 476 39 121 636 69 13 10 92 728
upf123e 529 43 133 705 106 15 18 139 844
dcp1 0.01432 664 46 133 843 278 28 35 341 1184
xrn1 0.02426 640 41 116 797 361 34 38 433 1230
a The q value computed by the SAM (Significance Analysis of Microarrays) software represents the threshold of significance for finding accumulated or decreased transcripts.
b ORFs indicates transcripts encoded by protein-coding genes on the chromosomes.
c Further elements represents transcripts encoded by genes of rRNAs, tRNAs, small RNAs, and RNAs encoded by transposable elements and their LTRs.
d Further ORFs, non-annotated or putative ORFs identified by the genome sequence project and by serial analysis of gene expression as well as genes of DNA plasmids or those
encoded on the mitochondrial genome.
e upf123 is the combination of transcriptomic profiles of each of the three UPF genes.
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scripts showed a changed mRNA level in comparison with the
wild type.
Two genome-wide studies of transcriptomic profiles from
UPF123,DCP1, andXRN1 knock-out yeast strains have been per-
formed (41, 50). The transcriptomes of the eIF5A-tsmutant were
compared with NMD-deficient strains using primary microar-
ray data published by He et al. (41) by performing the same
normalization and statistical analysis procedures with all
hybridization datasets.
Knock-out of any of the UPF genes resulted in the up-regu-
lation of 705ORFmRNAs (see Fig. 6,A andB, upper left circles)
including Ty retrotransposons and their LTRs. On average 139
transcripts were found to be depleted (Fig. 6C, upper left circle).
The dcp1 and xrn1 strains showed a higher number of reg-
ulated ORFs (Table 3). 843 ORFs in the dcp1 and 797 in the
xrn1 strains accumulated.
Among the up-regulated RNAs in theV81G strain numerous
transcripts overlapped with those up-regulated in strains bear-
ing knock-outs of components in either the NMD or 5–3
mRNA degradation pathway, respectively (Fig. 6A). 243 tran-
scripts (59%) of the on average 415 increasing ORFs in the
mutant were also up-regulated within the pool of up-regulated
transcripts of upf123 strains. Compared with those tran-
scripts up-regulated in xrn1/dcp1 strains the overlap was
about 10% lower (208 ORFs in comparison with dcp1 and 194
ORFs in comparison with xrn1 strains, representing 50 and
47% of the enriched transcriptome of V81G). Examination of
the down-regulated transcripts in NMD and hyp-deficient
strains showed no significant overlap (Fig. 6C).
Determination of mRNA Steady States and Decay Rates—To
validate the obtained microarray data and to find evidence that
the accumulation of mRNAs in V81G was due to a direct
mRNA decay defect in the mutant and not due to indirect
effects that influence mRNA levels, mRNA steady states and
decay rates of selected transcripts were measured.
Therelative levelsofnine transcripts found toaccumulate in the
V81G strainwere analyzed byNorthern blotting (Fig. 7A) and real
time (reverse transcriptional) PCR (Fig. 7B) after the cells were
cultivated at 25 °C. These transcripts were shown to be up-regu-
lated thus supporting themicroarray results. Two additional tran-
scripts of factors that function in telomere length control (EST1
and STN1) were quantified and also found to be up-regulated in
themutant. FurthermoremRNA stability was determined for five
transcripts (Fig. 7C). Specifically the intron containing CYH2
pre-mRNA, a direct target of NMD, showed only a slightly pro-
longed half-life in themutant at the permissive temperature com-
pared with the wild type. After a shift to 37 °C and a further incu-
bation for 1 h the transcript was stabilized with a decay rate
decreasing by a factor of 15 (Fig. 7, left).
The ARN1 and BSC4 transcripts
accumulated similarly in V81G and
NMD knock-out strains (41). 3–5-
fold increased half-lives were deter-
mined for both transcripts at 37 °C
in the mutant strain. Based on the
microarray data the transcripts of
the 40 S ribosomal protein S5
(RPS5) and GAPDH2 (TDH2)
served as negative controls. Both
transcripts showed no differences in
RNA half-lives (Fig. 7C) between
the wild-type and V81G strains.
Shortening of Telomeres in V81G
Mutant Strains—In the eIF5A
mutant several mRNA species of
genes with functions in the metabo-
lism of telomeres, including the
telomerase catalytic subunit encoded
by EST2, were significantly up-regu-
FIGURE 5. Distribution of telomeric and non-telomeric ORFs within the
group of up-regulated transcripts in V81G strains. The bar code distribu-
tion (divided into four parts) represents 345 up-regulated ORFs in the mutant
sorted in a descending order for their mean -fold change factors. The number
of telomeric ORFs increases with increasing -fold change factors (indicated by
the punctured trend line). In accordance most transcripts showing slight
increases are not positioned near telomeres of chromosomes. Also informa-
tion about the distribution and number of transcripts of Ty retrotransposons
(including their LTR elements) and ORFs being located near Ty elements and
Ty-LTRs on the chromosomes is included.
FIGURE 6. Overlap between the transcriptomic datasets of the HYP mutant V81G and nmd yeast strains.
A and B, overlap of elevated transcriptomes. The upper left sections named upf123 represent the combined
number of elevated ORFs in strains carrying disruptions in one, two, or all three UPF genes (41). The number of
elevated transcripts in xrn1 or dcp1 strains is contained in the upper right sections. The overlaps of both
groups of elevated ORFs in NMD-deficient strains to those measured in the V81G strains are shown. The arrows
mark the number of overlapping transcripts equally present in two groups of accumulating transcripts. Of 415
significantly up-regulated transcripts in V81G 59% (243) were also up-regulated in the upf123, and 50%
(208)/47% (194) were up-regulated in the dcp1/xrn1 yeast strains. C, the three groups of decreasing tran-
scripts do not show significant overlaps.
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lated (see supplemental Table S1). For this reason we wanted to
know whether this caused any effect on the telomere metabolism
in V81G. Hence the length of the telomeres was compared in the
mutant and wild-type strains.
After digestion of genomic DNA isolated from the relevant
strains that were incubated at 25 and 37 °C, respectively, a ter-
minal telomere fragment of about 800 bp was released from the
bigger telomeric regions (Fig. 8). The band contained Y
telomere-associated sequences that can be probed by Southern
blotting using a DNA fragment that included the telomeric
T(G1–3/C1–3)A repeats. The bigger fragments seen on the blot
internally contained other subtelomeric fragments that hybrid-
ize to the T(G1–3/C1–3)A probe.
As shown previously by other groups (46, 51, 52) the disrup-
tion of one ormoreUPF genes causes a reduction of the average
telomere length by about 65 bp. This result was reproduced
using genomic DNA of a upf1 strain (Fig. 8, lane 3). A com-
plementing UPF1 plasmid was capable of restoring the short-
ening in this upf strain. V81Gmutant strains cultured at 25 °C
developed a shortening of telomeres in the same range as the
upf strains dependent on their population doublings (PDs)
(Fig. 8, lanes 4–8). Newly isolated V81G strains from 5-fluo-
roorotic acid screening showed the same telomere length as
wild-type strains of the same age tested in parallel. Shorter
telomeres were observed when the PD number of the mutant
strains exceeded 25. The connection between the strength of
telomeric erosion and the age of themutant is also supported by
the observation of decelerated growth with increasing PDs of a
cultured strain (data not shown). Interestingly hardly any telo-
meric signals were obtained when probing V81G genomic
DNA samples that were isolated from cultures incubated at
37 °C for 12 h. This correlates with the observed apoptotic cell
death confirmed by TUNEL analysis and caspase activation
assays. Taken together, the data suggest that the mutated HYP
function caused a short telomere phenotype that is similar to
that seen when the NMD pathway is inactive.
DISCUSSION
In this work phenotypic effects of a distinct temperature-
sensitive pointmutated variant of eIF5Awere investigated. Val-
entini et al. (20) provided the first evidence for the importance
of the proline residue at position 83 in yeast Hyp2p. This region
was further investigated in this study using the human protein.
Interestingly the analogous proline 82 substitution resulted in a
lethal phenotype further underscoring the importance of this
residue within the protein. Mutational analysis of neighboring
amino acids gave rise to the use-
ful temperature-sensitive mutant
V81G. Homology modeling of the
tertiary structure of human EIF5A1
(53) revealed that it consists of two
domains similar to those known
from hyperthermophilic Archaea
(54). By way of analogy residue 81 of
the human protein is most likely
positioned at the beginning of a flex-
ible hinge region connecting both
domains. The glycine mutation
therefore may change the orienta-
tion of both domains with respect to
each other possibly bringing about a
disturbance in function.
Because of the pivotal cellular
role of eIF5A we were interested in
gaining more insight into the func-
tion of the human protein. A large
library of human EIF5A1 mutants
was screened resulting in the dis-
covery of specific temperature-sen-
sitive yeast strains. It is of note that
human EIF5A1 permitted normal
growth of yeast cells expressing the
allele as the unique source of eIF5A
(4, 5). This also indicates that the
high degree of conservation of
eIF5A ensures the same basic func-
tions of the protein in S. cerevisiae
and higher eukaryotes.
To analyze phenotypic effects it
was important to test the viability of
growth-arrested V81G cells. As
FIGURE 7. Validation of microarray data. A, determination of mRNA steady states by Northern blotting
(cultures grown at 25 °C). Total RNA was extracted and analyzed using probes complementary to six chosen
transcripts that showed the highest accumulation in the HDOA analysis (with the exception of STN1 and EST1).
Expression levels were normalized to the GAPDH2 (TDH2) transcript amount. B, real time (reverse transcrip-
tional) PCR quantification of six further genes (ratios are relative to the wild type). The ACT1 mRNA served as a
housekeeping gene. Bold numbers in parentheses correspond to the accumulation factor of each mRNA gen-
erated by microarray analysis. C, measurement of mRNA half-lives. Cultures from wild-type and mutant strains
were incubated at 37 or 25 °C for 1 h. 20 g/ml thiolutin was added, and the total RNA was extracted from
culture aliquots taken at the times indicated. Northern blotting was performed using 12 g of RNA/lane.
Digoxigenin-labeled DNA probes complementary to about 350 bp of the five target RNAs were used including
an intron containing the CYH2-pre mRNA and two accumulating transcripts found by the HDOA analysis of
V81G (mRNAs of BSC4 and ARN1). The mRNAs of glyceraldehyde-3-phosphate dehydrogenase 2 (TDH2) and 40
S ribosomal protein S5 (RPS5) served as negative controls. WT, wild type; hum, human.
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shown in Fig. 3 a significant reduction was shown after 6 h at
37 °C. At the same time themutant showed initial signs of DNA
fragmentation and activation of caspases, which are diagnostic
markers of apoptotic death (35, 55).Other researchers have also
demonstrated the involvement of eIF5A in the apoptotic pro-
cesses (56, 57). The induction of apoptosis is often linked to the
control of the cell cycle and the DNA damage checkpoint. Sev-
eral indications exist that eIF5A is involved in cell cycle pro-
gression from G1 to S phase (11, 58). Notably V81G cells at the
restrictive temperature showed characteristics of cells arresting
in the G1 phase of the cell cycle as indicated by their bud for-
mation (data not shown). Therefore, a connection between the
apoptotic behavior of V81G and the cell cycle arrest seems
probable. Further experiments are needed to gain more insight
into the apoptotic mechanism in these strains. However, corre-
lation of the strongly reduced protein level of mutated eIF5A
after incubation for 1 h at 37 °C with a loss of viability is most
likely one of the triggers of the ts phenotype and of the induc-
tion of apoptotic death.
Interestingly the addition of up to 1 M sorbitol to themedium
caused hyperosmolarity but neither reduced the temperature
sensitivity nor altered growth behavior of themutant. This is in
contrast to the properties of the proline mutants published by
Valentini et al. (20) who showed a significant attenuation of
temperature sensitivity with the addition of sorbitol. The
authors of that study suggested an involvement in the PKC1-
dependent signaling pathway for cell wall integrity. Our results
rather indicate different or additional effects of the V81G
mutant on the eIF5A function.
Transcriptome analysis revealed 60% overlap of the up-
regulated mRNAmolecules in V81G and NMD-deficient yeast
strains. Many of these overlapping transcripts could be
assigned to known substrate classes of NMD (41, 50). These
groups include Ty retrotransposal RNAs, their LTRs, and
mRNAs possessing disabling elements. Among these are genes
requiring 	1 frameshifts or containing premature stop codons
that are not caused by nonsense mutations (e.g. BSC4 and
BSC5). These findings point to a functional connection
between the eIF5A function and the 5–3-directed mRNA
degradation pathway including the nonsense-mediated decay
pathway. The microarray data from the NMD knock-out
strains indicated that this pathway not only degrades nonsense
transcripts of which the translation would lead to potentially
harmful truncated proteins but also regulates the activity of a
subset of normal yeast genes. A significant portion of the
mRNAs from these genes were up-regulated in the V81G strain
(see supplemental data for details).
These results are in line with findings that a C-terminal point
mutant of Hyp2p showed a strong stabilization of the intron
containing the CYH2 pre-mRNA (9). In addition a 30% reduc-
tion in the rate of protein synthesis was observed. The accumu-
lation of RNAs lacking the 5-cap proposed a function for eIF5A
in general mRNA degradation downstream of the decapping
step. The number of overlapping ORFs with the core tran-
scripts of the upf123 strains was about 10% higher than those
of xrn1 and dcp1 strains (Fig. 6). However, further experi-
ments will be necessary to clarify the exact role of eIF5A within
the pathway. At least one-third of the accumulating transcripts
from the V81G strain were not found among those of NMD-
deficient strains. The hypusine-containing protein has been
found to be essential in yeast, whereas the knock-out of NMD
does not lead to a cell cycle arrest and apoptotic death. These
facts are strongly suggestive of the involvement of eIF5A in
further biological processes.
The accumulation of nonsense transcripts and the stabiliza-
tion of the CYH2 pre-mRNA were already detected at the per-
missive temperature. A short incubation time of 60min at 37 °C
was sufficient to increase the CYH2 half-life by a factor of 15.
These facts suggest that the mRNA degradation deficiency is a
direct rather than an indirect effect. Measurement of mRNA
steady states of selected transcripts confirmed the results
obtained by the HDOA analysis (Fig. 7). Evidence that these
elevated mRNA levels in the mutant were related to a defect in
the Upf-dependent mRNA decay pathway was supplied by the
determination of the mRNA half-lives of three NMD-depend-
ent transcripts. The TDH2 and RPS5 mRNAs were not found
among the group of elevated RNAs, neither in the NMD-defi-
cient strains nor in the V81G strain, and did not show delayed
decay. These findings contradict the interpretation that a gen-
eral defect in mRNA degradation is present in the mutant.
FIGURE 8. Comparison of telomere length. V81G mutant strains exhibit
shortened telomere tracts depending on their number of PDs after isolation.
Total genomic DNA was digested with PstI, and fragments were separated on
a 1% agarose gel before blotting. Detection of bands by chemiluminescence
was achieved using a dioxigenin-5-labeled oligo as a probe against a
telomere repeat sequence and an anti-digoxigenin peroxidase-coupled anti-
body. The arrow indicates a fragment of 800 bp that contains 520 bp of the
Y telomere-associated sequence and about 280 bp of the telomere repeat
sequence T(G1–3/C1–3)A. Lanes 1 and 2, two clones of upf1

 strain PLY118
retransformed with the single copy plasmid pAA79 bearing a functional UPF1
gene; lane 3, PLY118 transformed with the empty pAA vector; lanes 4 and 5,
wild-type strains WDH(hum)Gal expressing human EIF5A1 cultured for 50 or
25 PDs at 25 °C; lanes 6 – 8, WDH(G81)Gal mutant strains expressing human
EIF5A1 carrying the V81G point mutation cultured for 50, 25, or two PDs at
25 °C; lanes 9 –11, same strains as in the previous lanes, but the cultures were
incubated at 37 °C for 12 h; lane 12, wild-type strain WDH(hum)Gal incubated
at 37 °C for 12 h.
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V81G strains displayed a distinct impairment of the telomere
positioning effect. In addition the microarray analysis also
revealed the accumulation of transcripts of genes playing a
direct role in the metabolism of telomeres and of the catalytic
subunit of the telomerase itself (supplemental Table S1). We
also showed that the V81G mutation leads to a short telomere
phenotype (Fig. 8). The same observations were described for
NMD-deficient yeast strains that also develop a shortening of
telomeres in the range seen in V81G strains.
There is solid evidence that theNMDpathway is essential for
telomere metabolism and telomerase function in yeast (51, 52,
46) and that several genes that control telomerase activity like
STN1, EST3, and EST1 are regulated by NMD as well (51). The
EST1 and EST2 transcripts were found to accumulate, and the
EST1 mRNA was found to be stabilized in V81G cells. Addi-
tionally it is known that increased levels of telomerase-regulat-
ing genes cause short telomere phenotypes, and overexpression
of STN1 and EST2 leads to reduced telomeric silencing (51)
similar to that seen in V81G. Therefore, the results strongly
suggest that the telomeric effects caused by the eIF5Amutation
could be explained via the influences of eIF5A on the NMD
pathway, disturbing the natural expression levels of telomer-
ase-regulating genes. Another possibility that is not mutually
exclusive to this would be that the stabilization of special tran-
scripts could lead to a down-regulation of translation of their
corresponding proteins causing a lack of function of these genes
and leading to a dysfunctional telomerase or reduced telomeric
silencing.
As the mutant form of eIF5A was expressed at a level com-
parable to the wild type at 25 °C (Fig. 2) the telomeric effects
cannot be due to a decreasing eIF5A protein amount but point
to further effects caused by themutant already at the permissive
temperature. Thus, the results gained from V81G at this tem-
perature are relevant even if they do not obviously contribute to
its strong temperature sensitivity.
There is evidence for eIF5A involvement in cellular senes-
cence (21, 22, 23). We observed that the growth of the V81G
mutant cells significantly decelerated with increasing popula-
tion doublings indicative of a senescent phenotype. Yeast
strains deficient in expressing the telomerase cofactors EST1
and EST3, which are both substrates of NMD, also show char-
acteristics of accelerated aging (59). This points to the involve-
ment of eIF5A in the senescence processes that could be
explained by its NMD-dependent regulatory effect on telomere
maintenance.
In all Archaea investigated so far deoxyhypusine synthase
and eIF5A have been found to be highly conserved proteins
indicating a related function for both proteins in Archaea and
eukaryotes. Upf1p is a highly conserved RNA helicase in the
NMDpathway, and it is highly likely that it has evolved from an
ancient ancestor of Archaea and eukaryotes (60), and RNA
metabolism itself is conserved in all eukaryotic systems (61).
This points to a co-evolution of eIF5A and NMD proteins and
suggests a functional connection between these factors.
The observed partial reduction of translationwhen depleting
eIF5A in yeast (8, 9) raised the hypothesis that eIF5A might
have a role in the translation/degradation of a specific subset of
mRNAs. Further work is needed to prove whether this subset
overlaps with the group of genes regulated by NMD. eIF5A
wouldthereforeinfluencethestabilityofasectionoftheseNMD-
dependent mRNAs before translation. The recognition of non-
sense mutations and initiation of translation are intimately
linked processes located at ribosomes. It is thus all the more
interesting that eIF5A has been found to interact with the ribo-
somal protein L5 (62). In addition the direct interaction with
translating 80 S ribosomes dependent on RNA and the
hypusine modification has recently been shown (63).
In summary the eIF5A function is slowly beginning to yield to
current molecular biological analysis. In the future elucidating
the detailedmechanistic connection of eIF5A andNMDwill be
of great interest.
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